(Q71059784)
Statements
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study (English)
C P Steuber
J Krischer
T Holbrook
B Camitta
V Land
C Sexauer
D Mahoney